WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
40.59 USD   +1.30%
08/11Health Care Down on Regulatory Concerns -- Health Care Roundup
DJ
08/11MARKETSCREENER’S WORLD PRESS REVIEW : August 11, 2022
MS
08/10JUDGE : Walgreens contributed to San Francisco opioid crisis
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wall St slides, Dow set for worst first-half since 1962

06/30/2022 | 12:28pm EDT

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.)

* U.S. May consumer spending rises moderately; inflation higher

* S&P 500 headed for worst first-half since 1970

* Indexes down: Dow 0.72%, S&P 0.58%, Nasdaq 0.81%

June 30 (Reuters) - U.S. stocks slipped on Thursday, setting the Dow up for its worst first six months since 1962, on concerns that a dogged pursuit by central banks to tame inflation would hamper global economic growth.

Fears over slowing growth and surging prices have rippled through markets, with recession worries taking center stage as monetary policymakers across the world look to aggressively raise borrowing costs.

Federal Reserve Chair Jerome Powell on Wednesday vowed to not let the U.S. economy slip into a "higher inflation regime", even if it means raising interest rates to levels that put growth at risk.

The tech-heavy Nasdaq Composite came off session lows but was still set for its largest declines ever for the first-half, while the benchmark S&P 500 tracked its biggest January-June percentage drop since 1970.

All the three main indexes are on course to post their second straight quarterly declines for the first time since 2015.

Fed policymakers in recent days have set expectations for a second 75-basis points interest rate hike in July even as economic data painted a dour picture of the American consumer.

"Until inflation meaningfully rolls over which at this point will take, I believe months, it's going to be hard for the market to really find a bottom and begin a rally," said Ross Mayfield, investment strategy analyst at Baird.

Meanwhile, consumer spending, which accounts for more than two-thirds of U.S. economic activity, rose less than expected in May, indicating a tepid rebound in growth in the second quarter, while inflation maintained its upward trend.

"A lot of investors were expecting inflation data to really start to come down. But what we're finding is that it's a lot more challenging, and that the inflation data is remaining elevated for longer and probably has not peaked," said Sam Stovall, chief investment strategist at CFRA.

Large-cap growth stocks including Microsoft Corp, Apple Inc, Amazon.com Inc and Tesla Inc fell between 0.5% and 2%, leading declines for the day.

At 12:01 p.m. ET the Dow Jones Industrial Average was down 224.38 points, or 0.72%, at 30,804.93, the S&P 500 was down 22.26 points, or 0.58%, at 3,796.57 and the Nasdaq Composite was down 90.17 points, or 0.81%, at 11,087.72.

Heading into the second half of the year, bruised markets will continue to focus on inflation, unemployment and interest rate increases along with their impact on corporate earnings.

"There's a sense that the earnings picture is going to be the next shoe to drop and that downward revisions to earnings will catalyze another leg lower in the market," Baird's Mayfield said.

Walgreens Boots Alliance Inc fell 4.5% as the drugstore chain maintained its full-year earnings forecast due to declining COVID vaccinations.

Declining issues outnumbered advancers for a 1.87-to-1 ratio on the NYSE and for a 1.79-to-1 ratio on the Nasdaq.

The S&P index recorded one new 52-week high and 42 new lows, while the Nasdaq recorded 11 new highs and 332 new lows.

(Reporting by Shreyashi Sanyal and Amruta Khandekar in Bengaluru; Additional reporting by Medha Singh; Editing by Arun Koyyur)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMAZON.COM, INC. 2.07% 143.55 Delayed Quote.-13.90%
APPLE INC. 2.14% 172.1 Delayed Quote.-3.08%
MICROSOFT CORPORATION 1.70% 291.91 Delayed Quote.-13.20%
TESLA, INC. 4.68% 900.09 Delayed Quote.-14.83%
WALGREENS BOOTS ALLIANCE, INC. 1.30% 40.59 Delayed Quote.-22.18%
All news about WALGREENS BOOTS ALLIANCE, INC.
08/11Health Care Down on Regulatory Concerns -- Health Care Roundup
DJ
08/11MARKETSCREENER’S WORLD PRESS REVIEW : August 11, 2022
MS
08/10JUDGE : Walgreens contributed to San Francisco opioid crisis
AQ
08/10Walgreens prescriptions added to San Francisco's opioid epidemic - judge
RE
08/10Walgreens prescriptions contributed to opioid epidemic in San Francisco - U.S. court
RE
08/04MARKETSCREENER'S WORLD PRESS REVIEW : August 4, 2022
MS
08/04A Young Population, Innovation and Technology Will Transform Africa
AQ
08/03Tennessee sues Walgreens pharmacy chain over opioid distribution
RE
08/03Tennessee sues Walgreens over opioid prescription onslaught
AQ
07/27Danone sends 1.3 mln cans of Aptamil baby formula to U.S. to address shortage
RE
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Financials (USD)
Sales 2022 132 B - -
Net income 2022 5 269 M - -
Net Debt 2022 9 403 M - -
P/E ratio 2022 6,67x
Yield 2022 4,75%
Capitalization 35 080 M 35 080 M -
EV / Sales 2022 0,34x
EV / Sales 2023 0,31x
Nbr of Employees 258 500
Free-Float 60,9%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 40,59 $
Average target price 42,84 $
Spread / Average Target 5,55%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Kevin M. Ban Chief Medical Officer
Sector and Competitors